Skip to search formSkip to main contentSkip to account menu

PV701

Known as: PV 701, PV-701 
An attenuated, replication-competent, oncolytic strain of Newcastle disease virus. PV701 selectively lyses tumor cells. The selectivity of this agent… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Development of effective vaccines for the immunotherapy of cancer or persistent infectious disease will require the reactivation… 
Highly Cited
2007
Highly Cited
2007
Purpose: Previous phase 1 trials of i.v.-administered PV701 have shown this virus to be well-tolerated with toxicity primarily… 
Review
2007
Review
2007
PV701 is a naturally-attenuated, non-recombinant, oncolytic strain of Newcastle disease virus that displays preclinical… 
Review
2007
Review
2007
We are very pleased and proud to be able to publish this special issue of Current Cancer Drug Targets devoted to oncolytic virus… 
2007
2007
PV701 is a highly purified, replication-competent naturally attenuated strain of Newcastle disease virus, an avian paramyxovirus… 
Highly Cited
2006
Highly Cited
2006
Purpose: In a previous phase 1 study, adverse events, especially flu-like symptoms, were observed mainly following the first i.v… 
2004
2004
3037 Background: PV701 is a non-recombinant, replication-competent Newcastle disease virus that targets tumor-specific defects in… 
Review
2003
Review
2003
PV701 is an attenuated, non-recombinant, oncolytic strain of Newcastle disease virus that displays preclinical intravenous (i.v… 
Highly Cited
2002
Highly Cited
2002
PURPOSE PV701, a replication-competent strain of Newcastle disease virus, causes regression of tumor xenografts after intravenous…